A hemagglutination-based, semi-quantitative test for point-of-care determination of SARS-CoV-2 antibody levels
Robert L. Kruse, Yuting Huang, Alyssa Lee, Xianming Zhu, Ruchee Shrestha, Oliver Laeyendecker, Kirsten Littlefield, Andy Pekosz, Evan M. Bloch, Aaron A.R. Tobian, Zack Z. Wang
doi: https://doi.org/10.1101/2021.05.01.21256452
Robert L. Kruse
1Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland
Yuting Huang
2Department of Medicine, University of Maryland Medical Center Midtown Campus, Baltimore, Maryland
Alyssa Lee
3Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
Xianming Zhu
1Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland
Ruchee Shrestha
3Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
Oliver Laeyendecker
3Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
Kirsten Littlefield
4Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
Andy Pekosz
4Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
Evan M. Bloch
1Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland
Aaron A.R. Tobian
1Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland
Zack Z. Wang
3Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
Article usage
Posted May 04, 2021.
A hemagglutination-based, semi-quantitative test for point-of-care determination of SARS-CoV-2 antibody levels
Robert L. Kruse, Yuting Huang, Alyssa Lee, Xianming Zhu, Ruchee Shrestha, Oliver Laeyendecker, Kirsten Littlefield, Andy Pekosz, Evan M. Bloch, Aaron A.R. Tobian, Zack Z. Wang
medRxiv 2021.05.01.21256452; doi: https://doi.org/10.1101/2021.05.01.21256452
A hemagglutination-based, semi-quantitative test for point-of-care determination of SARS-CoV-2 antibody levels
Robert L. Kruse, Yuting Huang, Alyssa Lee, Xianming Zhu, Ruchee Shrestha, Oliver Laeyendecker, Kirsten Littlefield, Andy Pekosz, Evan M. Bloch, Aaron A.R. Tobian, Zack Z. Wang
medRxiv 2021.05.01.21256452; doi: https://doi.org/10.1101/2021.05.01.21256452
Subject Area
Subject Areas
- Addiction Medicine (382)
- Allergy and Immunology (699)
- Anesthesia (190)
- Cardiovascular Medicine (2838)
- Dermatology (243)
- Emergency Medicine (427)
- Epidemiology (12545)
- Forensic Medicine (10)
- Gastroenterology (801)
- Genetic and Genomic Medicine (4419)
- Geriatric Medicine (401)
- Health Economics (713)
- Health Informatics (2845)
- Health Policy (1046)
- Hematology (373)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4173)
- Nursing (221)
- Nutrition (615)
- Oncology (2199)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (317)
- Pain Medicine (266)
- Palliative Medicine (81)
- Pathology (485)
- Pediatrics (1171)
- Primary Care Research (482)
- Public and Global Health (6768)
- Radiology and Imaging (1487)
- Respiratory Medicine (898)
- Rheumatology (430)
- Sports Medicine (368)
- Surgery (473)
- Toxicology (57)
- Transplantation (200)
- Urology (173)